









PATTERNS OF DEATH, 1800–2020
Global rates and causes
Romola Davenport
(CC-BY-NC-ND 4.0)
This OA chapter is funded by Wellcome Trust
1
PATTERNS OF DEATH, 1800–2020
Global rates and causes1
Romola Davenport
This chapter provides a brief introduction to mortality patterns over the last two cen-
turies from a global perspective. The period witnessed enormous and ubiquitous rises
in life expectancy at birth, from a global average of perhaps 30 years in 1800 to an
estimated average of 72.6 years in 2019.2 Remarkably, these changes took place des-
pite a perhaps seven- to eight-fold increase of the world’s population, from around
1 billion in 1800 to 7.7 billion in 2020,3 and in the context of unprecedented
increases in the speed and frequency of transmission of infectious diseases as
a consequence of urbanization, colonization, technological change, and the globaliza-
tion of trade. This chapter will outline the broad geography and chronology of
changes in patterns of mortality and will introduce debates regarding the role of eco-
nomic growth and those of medicine and states. It concludes with a discussion of
recent and future trends.
The wide chronological and geographical reach of the chapter necessitates an imme-
diate caveat. For much of the world, we know very little about mortality rates or levels
for national populations before the mid-twentieth century at the very earliest. The
United Nations began to publish estimates of mortality rates and data on causes of
death for member states in 1950; however, these series are very incomplete and in
many cases rely on estimates from rather fragmentary data, even now. For most of
sub-Saharan Africa, scholars and public health systems remain reliant on epidemio-
logical surveillance centers and international survey data, and even the largest states,
India and China, still use sample registration and surveillance systems in lieu of com-
plete registration of all deaths by age and cause.4 Given these limitations regarding
national patterns and trends, we naturally know even less about health and mortality
amongst subgroups within national populations, and about the heterogeneity of experi-
ences in historical societies. This chapter therefore offers a rather impressionistic and
selective view of the profound changes in mortality patterns that have occurred in the
last two hundred years.
Ages and stages
In the broadest terms, what the economist and demographer Richard Easterlin dubbed
the ‘Mortality Revolution’ was predominantly a function of enormous reductions in infec-
tious disease mortality.5 These diseases had their greatest impacts on young children and
young adults, and therefore mortality improved first and fastest in these age groups.
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Since 1800 death has been ever-increasingly confined to the extremes of life, in early
infancy and old age, and infectious diseases have given way to non-communicable dis-
eases, especially cancers, strokes and cardiovascular diseases, and, increasingly, dementia,
as more and more people live to the ages where these diseases predominate. Latterly,
improvements in the prevention and treatment of non-communicable diseases have
improved survival even at the oldest ages, further extending life expectancy. These pat-
terns have, however, unfolded with very different chronologies in different parts of the
world, and with some notable reversals.
Figure 1.1 presents this mortality transition in stylized form for the population of Eng-
land and Wales. Panels a and b represent the situation in 1841. By 1841, as discussed
below, the English population was already free of famine, and major mortality crises
were extremely rare. Nonetheless, life expectancy at birth was only 42 years, and infec-
tious diseases accounted for nearly half of all deaths. Panel a illustrates the chance of
survival to each age, using a hypothetical population of 1,000 people. We have to
imagine that these people were all born at the same time and lived their lives with the
mortality rates of the English and Welsh population in 1841 (this is not what actually
happened to those born in 1841, most of whom were subject to substantial improvements
in prevailing mortality rates during their lives). This type of plot is termed a ‘survivorship
curve’, and shows the survivors of our hypothetical population, or cohort, at each age.
Of the 1,000 babies born in 1841, 138 would have been dead before their first birthday.
For those who survived infancy, the risk lessened; however, a quarter of all those born
would not survive to age 5. By age 47, half would be dead.
Panel b shows the distribution of these deaths by age, in 1841. Deaths were heav-
ily concentrated in infancy (the first year of life) and early childhood. However,
deaths in adulthood were also relatively high at all adult ages. This contrasts mark-
edly with the situation a century later. By 1950 almost everyone born into our hypo-
thetical cohort could expect to live to adulthood, and half would survive to 74.
Deaths had become concentrated overwhelmingly in late adulthood. The absolute
numbers of deaths were higher in late adulthood than in 1841, not because death
rates were higher at these ages in 1950, but because a far higher proportion of the
cohort now survived to these ages.
Comparison of panels a and c illustrates what has been termed the ‘rectangularization
of mortality’. This is the shift in the pattern of survival from a fairly constant downward
curve by age, as in panel a, to a more rectangular form, where most people survive until
late age, into their 70s or 80s, and there is a compression or a concentration of mortality
into these age groups. Panels e and f illustrate subsequent changes in the mortality pat-
terns of affluent populations since the mid-twentieth century. Broadly, there has been
a further ‘rectangularization’, and deaths are even more concentrated at the oldest ages.
However there has also been a shift of the whole survival curve to older ages. That is,
not only do most people survive to later ages (over half of our hypothetical cohort would
live to 85, under the mortality rates of 2016), but the age at which most of the popula-
tion has died has shifted to older ages.
Figure 1.1 also shows life expectancy measures for the population of England and
Wales in 1841, 1950, and 2016. Critically, life expectancy at birth is not the age by
which most of the population would be dead, as is sometimes assumed. Rather, it is the
average age at death. This means that even in populations with relatively low life expectan-
cies, a substantial proportion of adults lived into their sixties and seventies. Indeed, as
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can be seen in Figure 1.1, the average age at death is usually lower than the age to
which half the population could expect to survive, because the former figure takes into
account how many years people lived. High death rates in childhood lower the average
age at death because they contribute only very small values to the sum of ages at death.
Life expectancy is calculated using hypothetical populations, as in our example, instead
of actual populations because the average age at death in real populations is affected by
the age structure of the population. The age structures of populations, and therefore the
average age of death, can vary very considerably over time and between populations for
Figure 1.1 Distributions by age of survivors (a, c, e) and deaths (b, d, f) in a synthetic cohort subject to
the death rates prevailing in the population of England and Wales in 1841, 1950, and 2016.
Source: Human Mortality Database (University of California, Berkeley), and Max Planck Institute for Demographic
Research (Germany), www.humanmortality.de (downloaded on January 2, 2020).
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reasons other than prevailing mortality rates, including historical changes in fertility,
mortality, and age-specific migration rates.
Figure 1.1 depicts the very profound changes in mortality patterns that occurred in
the population of England and Wales over the last 170 years. The rest of the chapter
considers the processes underlying these trends, and how widespread and uniform these
processes were globally.
Global patterns, an overview
How ubiquitous has this ‘mortality revolution’ been? Figure 1.2a shows estimates of
global average life expectancy since 1800, together with life expectancies for England
and Sweden. England and Sweden were forerunners in mortality improvements and in
the reporting of mortality statistics. The main pattern is clearly one of enormous
improvements in survival. These started first in Europe and amongst the settler popula-
tions of North America, Australia and New Zealand in the nineteenth century (or even
the mid-eighteenth century, in some cases) and extended to a small number of Latin
American and Caribbean countries by the late nineteenth and early twentieth centuries.6
On the other hand, it is likely that mortality rose in the nineteenth century in some
populations that had remained relatively isolated from global disease pools before this
period, including Japan, the indigenous populations of North America, Australasia and
the Pacific, and parts of tropical Africa.7
There is evidence for fairly widespread reductions in mortality globally after c.1920,
and by the 1940s mortality declines were apparently underway in a wide variety of set-
tings. The evidence for this is largely indirect and rests on the assumption that the very
high rates of population growth witnessed in most of the world by this date (producing
an estimated global rate of c.1.5 per cent per annum by 1950) were driven at least in
part by falling mortality, as well as rising fertility.8 These trends may have been inter-
linked. Where mortality declines were associated with improving adult and maternal
health, then this may have resulted in increases in fecundity (the potential to conceive)
and fertility.
Gains in life expectancy gathered speed in the second half of the twentieth century,
especially in poorer countries. By the early 1950s, when (often rather fragile) statistics
became available for many UN member states, the picture was one of enormous dis-
parities in mortality. According to an elegant analysis by Chris Wilson, the world’s
population was divided (unequally) between poor countries with low life expectancies
(averaging around 35–39 years) and rich or communist Eastern bloc countries with
average life expectancies of 65–69 years (Figure 1.3a).9 That is, the distribution of life
expectancies was fairly bimodal (two-peaked), with very little overlap between the two
groups. Within the space of 25 years, however, the picture had changed enormously.
By the late 1970s only a very small percentage of the world’s population lived in
states with average life expectancies below 40 years, and nearly 60 per cent of the
global population now lived in states with life expectancies of 60 years or more
(Figure 1.3b). By the twenty-first century there had been an enormous and almost ubi-
quitous convergence of life expectancies in rich and poor countries (Figure 1.3c). The
United Nations estimated that the average life expectancy of the global population in




Within this general pattern of improvement and global convergence there have also
been notable periods of stagnation and reversal. The most striking reversal was caused
by the HIV/AIDS pandemic. The most-HIV affected countries in sub-Saharan Africa
were in southern and eastern Africa and included some of those which had made the
greatest prior gains in life expectancy (most notably Botswana, Figure 1.2b). Life expect-
ancy is estimated to have fallen by 10 years in Botswana, South Africa, Namibia, and
Zambia, and 20 years in Swaziland during the 1990s and early 2000s, before embarking
Figure 1.2 Long-run trends in life expectancy at birth.
Data are annual estimates except in the case of England and Wales in panel a, which are five-year averages.
Sources: Human Mortality Database (University of California, Berkeley), and Max Planck Institute for Demo-
graphic Research (Germany), www.humanmortality.de (downloaded on January 2, 2020); M. Roser, E. Ortiz-
Ospina, and H. Ritchie, ‘Life Expectancy’, published online at OurWorldInData.org (2020), retrieved from
https://ourworldindata.org/life-expectancy [Online Resource]; E.A. Wrigley, R. S. Davies, J. E. Oeppen and
R. S. Schofield, English Population History From Family Reconstitution 1580–1837, (Cambridge: Cambridge Univer-
sity Press) (1997).
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Figure 1.3 The distribution of the global population by life expectancy.
Populations were distributed according to the estimated average life expectancy of each national population
(both sexes), except in the cases of India and China, where populations and life expectancies for states and
provinces were used.
Source: C. Wilson, ‘On the Scale of Global Demographic Convergence 1950–2000’, Population and Development
Review, 27 (2001), 155–171.
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upon a sustained recovery from around 2005, driven by the increasing availability of
retroviral therapies, as well as public health initiatives and behavioral changes.11
Another very marked reversal is the fall in life expectancy in some parts of the former
Soviet Union after the break-up of the union in 1991 (Figure 1.2b). This was preceded
by a prolonged stagnation in life expectancy and infant mortality in the USSR in the
decades of the 1960s–1980s. However, the collapse of communism in Europe precipi-
tated marked increases in mortality especially of adult Russian males after 1991,
a substantial proportion of which were alcohol-related.12 Another notable period of
stagnation occurred amongst adult males in many high-income countries in the period
c.1950–1980. The timing and extent of this slow-down varied by country and was closely
related to life-time smoking patterns. In the UK and the USA, males born in the late
1890s and early 1900s had the highest lifetime smoking rates, perhaps reflecting WWI
military policies to pay recruits partly in cigarettes. It was these men who experienced
the largest absolute rises in lung cancers and cardiovascular diseases in the third quarter
of the twentieth century, against a backdrop of steadily improving death rates for women
(See Figure 1.5).13
Epidemiological transitions
Can these enormous improvements in survival since 1800 be understood within a unified
model of epidemiological change? The most widely used descriptive model of mortality
decline is Abdel Omran’s ‘epidemiological transition’ framework.14 Omran described
a three-stage process that started with the ‘Age of Pestilence and Famine’, which he
regarded as the traditional state of large agrarian societies. In this state, life expectancy
fluctuated between 20 and 40 years, and population growth was slow or negligible. The
onset of secular mortality decline was associated with the ‘Age of Receding Pandemics’,
and included reductions in the level and volatility of mortality, and a progressive shift of
mortality from infectious to ‘degenerative’ diseases. This was followed by the ‘Age of
degenerative and man-made diseases’, as infectious diseases diminished decisively, and
most deaths occurred as a result of chronic non-communicable diseases (especially can-
cers and cardiovascular diseases) in late adulthood. Omran thought that gains in survival
would slow or cease in this stage. However, life expectancy has continued to rise inexor-
ably, driven largely by improvements in survival at advanced ages. This has led some
scholars to advocate a fourth stage, the ‘Age of delayed degenerative diseases’.15
Omran’s model is widely used; however, it is largely descriptive rather than analytical
and may be a poor representation of the historical processes at work in many societies.
In this section, we provide a very brief overview of mortality trends in England and com-
pare these with trends elsewhere. England is the only national population for which we
have very long-run and robust mortality data for the last half millennium (from the
1540s). It was also a forerunner in terms of mortality declines. We divide the discussion
into four periods: (1) c.1550 to 1750, when mortality crises abated and mortality stabil-
ized, albeit at lower levels of life expectancy; (2) 1750–1870, when some of the most
lethal infectious diseases including smallpox, typhus, malaria, and cholera were brought
under control in the English population; (3) 1870–1940, when an impressive range of
improvements in sanitation and hygiene, preventative medicine, and living standards pro-
foundly reduced mortality from childhood diseases and tuberculosis in European and
neo-European populations; and (4) the antibiotic era post-1940, when medical
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technologies including antibiotics and a range of vaccines acted in synergy with older
strategies to confine infectious disease mortality largely to the oldest ages in developed
countries. We conclude with a discussion of potential future trends.
Receding pandemics (1550–1750)
England was very precocious in escaping famine and major mortality crises. The last
nation-wide subsistence crisis in England occurred in the 1590s, and mortality crises
diminished progressively following the disappearance of plague after the 1660s.16 How-
ever, contrary to Omran’s model, life expectancy actually fell as food security improved
and epidemics subsided (Figure 1.2a). The most plausible explanation for this worsening
of mortality in the period 1650–1750 is that the urbanization and integration of the Eng-
lish economy that occurred in this period was accompanied by an epidemiological integra-
tion, that increased the circulation of infectious diseases. That is, the development of
a functioning national grain market and improved transport infrastructure, which helped
to reduce the impact of harvest failures, also promoted the spread of infections.17
Towns were also associated with high mortality, because they acted as hubs for dis-
ease importation and because poor sanitary conditions and dense populations facili-
tated the spread of gastrointestinal and airborne infections. As disease exposure
increased, many of the diseases that had caused rare but large epidemics in the past
became routine infections of childhood. This was the case for diseases that conferred
lifelong immunity on survivors.18 Thus in historical societies, urbanization, trade, and
economic growth tended to raise mortality rates and to concentrate some infectious
diseases in childhood.19
Receding famine and infectious diseases (1750–1870)
This process of worsening mortality was reversed after around 1750, in England and in
other populations of north-western Europe. The reasons for this reversal remain obscure.
Most puzzling is the fact that the largest improvements occurred in urban populations.
Before the late eighteenth century, cities in Europe appear to have been so lethal as to
require a constant flow of immigrants simply to maintain their populations. In early
eighteenth-century London, a third of infants died in the first year of life, and only about
60 per cent of those born in London survived to age 15.20 However, after 1750 urban
mortality rates improved very markedly, and cities became capable of maintaining their
own populations through natural increase, although mortality remained substantially
higher than in rural areas until the twentieth century.21 As Simon Kuznets argued, these
early improvements in urban mortality rates were an essential pre-requisite for the unpre-
cedented rates of urbanization that followed.22 With the death rates prevailing in early
modern cities, modern levels of urbanization would have caused the decline of national
populations.
Famine also receded from western Europe in the late eighteenth century (notwith-
standing the Great Famine in Ireland, 1845–1849, and the Finnish famine of
1866–1868).23 In the twentieth century, famine reappeared briefly in western Europe in
association with the extreme stresses of the two world wars. However at the global level,
the twentieth century witnessed some of the largest famines ever, including the Great
Leap Forward famine in China in 1959–1961 that may have killed 20–30 million
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people.24 Nonetheless, by the late twentieth century, the global impact of famine had
dwindled enormously, and even the most severe famines of recent decades (including
Somalia in 1991–1992 and North Korea in 1995–2000) have been small by historical
standards.25
There is lively debate about the causes of famines and whether famines are primarily
a function of declines in food availability or of institutional or market failures. Amartyr
Sen famously argued that modern famines represented a ‘failure of exchange entitle-
ments’, rather than an absolute shortfall in food supplies.26 That is, certain groups lose
their capacity to exchange their primary entitlement (for example, their labor) for food.
This may occur, for example, because the high price of food or other factors has reduced
demand for the products or services which they supply. The price of food may also bear
an ambiguous relationship to actual food availability. It may be driven up by demand
elsewhere or by hoarding or requisitioning in the absence of any shortfall in production.
Alternatively, as Malthus noted, prices may rise only modestly despite starvation, because
those starving are too poor to enter the market and to influence prices.27
Explanations for the disappearance of famine often focus on advances in agriculture and
food production, including the introduction of New World crops (especially potatoes and
maize), and, in the twentieth century, the Green Revolution in crop productivity that started
in the 1950s. However, in the English case, explanations for the early escape from famine
acknowledge the importance of favorable ratios of population to food production, but also
emphasize improvements in the operation of grain markets, on the one hand, and improve-
ments in institutional responses on the other, especially the English poor laws.28 Recent work
by Phil Slavin on the greatest famine in European history, that of 1315–1317, has revealed
clear evidence of hoarding of grain.29 Other studies of credit have demonstrated how the
impact of successive harvest failures in 1315–1317 was amplified in England by the actions
of landlords and even family members who took advantage of the crisis to engross landhold-
ings and other assets.30 Conversely, work by Richard Smith has demonstrated how these
practices were replaced, by the sixteenth century, with a parish-based system of taxation and
poor relief (before compulsory legislation). This system of communal welfare may have been
sufficient to avert severe mortality in the English population during the harvest failures of the
1590s and, more assuredly, in the dearth years of the 1690s, when perhaps 10 per cent of
the Scottish population died.31 These works raise the intriguing question of whether the early
disappearance of famine in Western Europe owed more to improvements in famine relief
measures and other institutional changes than to improvements in food production and
market distribution.
Another important element in the disappearance of famine (and more generally of
dearth-related mortality), is the control of epidemic diseases. It is likely that the immediate
cause of most famine-related mortality in historical populations (except perhaps in very iso-
lated and small-scale societies) was infectious diseases, rather than starvation. Typhus, or
‘famine fever’, was a common and lethal correlate of harvest failure, together with typhoid,
dysentery, and other diseases including smallpox and malaria.32 Epidemics generally accom-
panied major harvest failures because these failures often prompted migration in search of
work and food. Such migration brought rural populations into contact with novel diseases,
especially when they moved into towns, and exposed them to over-crowded and insanitary
conditions at a point when they were malnourished and probably immune-compromised.33
These epidemics also tended to become general, and therefore the mortality associated with
past famines may have been fairly socially unselective.34
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Reductions in epidemic disease mortality associated with famines probably occurred
via several mechanisms. First, where famine relief measures were relatively local and
effective (as in the English case from the late sixteenth or seventeenth century onwards),
these would have reduced migration and associated disease exposure. Second, disease
control measures played an increasingly important role over time. These started with
measures to isolate infected individuals and to disinfect clothing and bedding and
extended in the twentieth century to large-scale immunization and medical programs in
concert with often international famine relief measures. A grim testament to the effective-
ness of such measures is the famine associated with the siege of Leningrad. The city was
blockaded for nearly two years (1941–1943), and 800,000 civilians died, mainly of starva-
tion. However sanitary measures were so strictly adhered to that there was no major out-
break of epidemic disease.35 It is a peculiar achievement of the twentieth century that so
many famine victims escaped infectious diseases for long enough to starve to death.
Warfare too became less disease-prone in the eighteenth century, although it was not
until the early twentieth century that battle deaths exceeded those from disease during
military conflicts. Indeed eighteenth-century efforts to contain and prevent major disease
outbreaks in the navy; in prisons and workhouses; and on slave, convict, and immigrant
ships, probably led the way in developing effective techniques for reducing the transmis-
sion of contagious (person-to-person) and vector-borne diseases.36 These techniques
included epidemiological surveillance (first adopted in Italy against plague, and
entrenched in England in the form of the London bills of mortality), the isolation of indi-
viduals suspected of infection, contact tracing, surveillance, improved hygiene and diet,
and reductions in crowding. While many of these measures, such as obsessive ventilation,
were based on erroneous models of disease, others, such as isolation of the infected or
the issuing of new clothes to sailors, were of clear benefit regardless of their theoretical
justification.37 Perhaps more importantly, the publication and dissemination of these
ideas subjected them to wide scrutiny and replication.
Pre-eminent amongst the diseases that declined before the mid-nineteenth century was
smallpox. Smallpox was probably the single most lethal infectious disease in eighteenth-
century Europe and was also a major cause of death in the Americas and parts of Asia
and Africa. Although smallpox is usually considered an ancient disease of humans, its
origins remain obscure. Recent breakthroughs in the sequencing of ancient DNA have
produced evidence that a new variant of smallpox may have spread through Europe and
then globally in the seventeenth century.38 By the second half of the eighteenth century,
smallpox was responsible for 8 per cent of all deaths in Sweden and northern England,
and 20 per cent in Manchester.39 Attempts to control smallpox through isolation of vic-
tims and inoculation with small doses of the virus were very widespread.40 However, the
advent of immunization with cowpox (vaccination), discovered by Edward Jenner in
1796, and published in 1798, proved a decisive turning point. Vaccination was immedi-
ately recognized as a godsend, and it spread rapidly through Europe and into European
colonies and ex-colonies, although its immediate effects varied enormously.41 It is difficult
to estimate the true impact of smallpox, and of vaccination, on global mortality trends.
This is because, first, vaccination was introduced well before most states introduced the
systematic measurement of cases and deaths, and second, smallpox appears to have
evolved into a number of subtypes with very different rates of mortality in the course of
the nineteenth century. Therefore, although smallpox is celebrated as the first disease to
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be eradicated by human efforts (declared in 1980), the true impact of smallpox on histor-
ical populations probably remains under-appreciated.
By 1820 then, mortality patterns in north-western Europe were already profoundly
different from previous centuries. Famine had receded, and the most lethal epidemic dis-
eases (plague, typhus, smallpox, and malaria) had waned decisively in impact. The mor-
tality associated with these diseases had been fairly indiscriminate, affecting wealthy and
well-nourished individuals as well as the poor. Indeed, there is little evidence for
a survival advantage to wealth before the nineteenth century.42 This is very surprising,
since it might be thought that the advantages of better diet, clothing, and housing would
have been even more important in the past, when living standards were lower. However,
as Stephen Kunitz and Stanley Engerman have argued, the disease environment may
have been sufficient to overwhelm these advantages before the nineteenth century.43 As
these more lethal diseases receded, then, mortality became concentrated amongst the
very young, the very old, and the poor. Because we know less about mortality patterns
before the nineteenth century, it is common to think of these patterns as traditional; how-
ever, they probably represented a new and ‘modern’ pattern compared with previous
centuries.44
In Britain further improvements in longevity were impeded after c.1830 by unprece-
dented rates of urbanization, and possibly by scarlet fever, which underwent an appar-
ently autonomous increase in virulence.45 However, in Sweden, where urbanization
remained very modest before the late nineteenth century, life expectancy improved fairly
continuously from 1750 to the present (Figure 1.2a). Woods has argued that similar
underlying improvements in health in Britain were masked by the rapid redistribution of
population from relatively healthy but poor rural areas to wealthier but unhealthier
urban ones.46
The eclipse of infectious diseases (1870–1940)
Rapid secular mortality decline resumed in England from c.1870, interrupted only by
the major wars and the 1918/19 influenza pandemic (Figure 1.2b). Most of the decline
in mortality between 1870 and 1940 was driven by declines in infection-related mortality
in children and young adults, with the most rapid improvements occurring in the period
1900–1940 (Figure 1.4).
Scarlet fever and respiratory tuberculosis mortality began to decline from the 1870s.
The other major ‘childhood’ diseases (measles, diphtheria, and pertussis) all underwent
very substantial and poorly understood declines in the period after 1900. In the case of
scarlet fever there is reason to think that the pathogen (Streptoccocus pyogenes) declined in
virulence, but no similar arguments have been made for other infections in this period,
with the partial exception of tuberculosis47 and streptococcal puerperal fever.48 These
childhood diseases are transmitted person to person and are highly infectious, and it
appears that reductions in mortality resulted from declines in case-fatality rates rather
than in incidence of infection. In the case of measles, Peter Aaby and colleagues have
made a strong case for the importance of crowding and dosage of infection to mortality
from measles.49 Improvements in nutrition associated with rising incomes doubtless acted
to increase host resistance. In addition, improvements in housing conditions and the pro-
gressive and substantial declines in fertility and family size from the 1870s would also
have acted to reduce infection dosage and exposure to opportunistic infections.50 The
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same constellation of factors probably contributed substantially to improvements in mor-
tality from tuberculosis (Figure 1.6), although in this case the extent to which incidence
of infection was also reduced via preventative measures such as confinement of sufferers
to sanitoria remains unknown.51
The most lethal waterborne diseases (cholera, typhoid, and dysentery) declined from
the 1860s. These trends imply early improvements in the quality of drinking water. How-
ever, diarrhoeal diseases displayed a more complicated pattern, declining from the 1870s
amongst adults and older children but remaining stubbornly high, and indeed rising in
Figure 1.4 Annual age-specific mortality rates, England and Wales, 1841–2011.
Panel a includes all age groups, panel b displays ages where mortality rates were comparatively low (and
declined early).
Source: Human Mortality Database (University of California, Berkeley), and Max Planck Institute for Demographic
Research (Germany), www.humanmortality.de (downloaded on January 2, 2020).
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Figure 1.5 Mortality by category of cause, ages 60–64, England and Wales, 1891–1967.
Dashed vertical lines indicate dates of changes in cause of death coding schemes. ‘Respiratory’ includes respira-
tory tuberculosis, influenza, and pneumonia; ‘circulatory’ includes strokes; ‘external’ includes all accidental and
violent deaths.
Source: R.J. Davenport, Annual Deaths By Cause, Age and Sex in England and Wales, 1848–1900 [dataset] (2007),
Economic and Social Data Services (SN5705); Office of National Statistics, ‘Twentieth Century Mortality: 100
Years of Mortality Data in England and Wales By Age, Sex, Year and Underlying Cause’ (2003).
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the 1890s, amongst infants.52 The late decline of infant diarrhoeal mortality may reflect
differences in disease transmission pathways between infants and other age groups.
Infants appear to have been relatively insensitive to water quality, in England, and diar-
rhoeal mortality in this age group was probably more closely related to sanitary condi-
tions (including sewerage and fecal disposal) and domestic practices (breastfeeding,
handwashing, and food preparation). Conversely, diarrhoeal diseases in older children
and adults were probably more closely related to the quality of drinking water.53
These patterns of declines in gastrointestinal (or ‘fecal-oral’) diseases present a puzzle,
because they fit very poorly with the traditional chronology of improvements in water
and sanitation in England, which were especially marked after 1870 (when urban author-
ities began to make very major investments in water provision and sewerage).54 The pre-
cocious declines of the most water-dependent diseases (cholera, dysentery, and typhoid)
pre-dated large-scale investments in water supplies and suggest that relatively cheap or
incomplete attempts by towns to source clean water may have been sufficient to reduce
transmission of these diseases, in many cases before investments in water purification or
sewerage. Conversely, infant diarrhoeal mortality was apparently unaffected by very
major investments in water supplies.55 However the installation of comprehensive urban
sewerage systems and sewage treatment lagged well behind investments in clean water
supplies, and the continued retention of large volumes of human excrement in many
British towns until the early twentieth century may account for the continued high levels
of infant diarrhoea against a backdrop of major declines in waterborne diseases.
Figure 1.6 Tuberculosis mortality, England and Wales, 1848–2000.
Death rates are directly age-standardized using the 2012 population of England and Wales. Source: R.J.
Davenport, Annual Deaths By Cause, Age and Sex in England and Wales, 1848–1900 [dataset] (2007), Economic and
Social Data Services (SN5705).
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This pattern, of precocious improvements in the most lethal waterborne diseases and
slower improvements in diarrhoeal diseases of early childhood was also evident globally
in the twentieth century. The more lethal ‘Asiatic’ cholera (which killed perhaps 15 per
100 of those infected) has been largely displaced since the 1960s by the ‘El Tor’ cholera
subtype, which has a case-fatality rate of around 1 death per 100 infections.56 Typhoid
and dysentery have also declined enormously as causes of death. Paul Ewald argued that
these changes in water-borne diseases reflected widespread improvements in water qual-
ity, which have dramatically reduced water-based disease transmission.57 The WHO and
UNICEF estimated in 2019 that 90 per cent of the global population now had access to
‘improved’ water sources (a clean source within 30 minutes’ round walk).58 Nonetheless,
infant diarrhoeal diseases still constitute some of the most common causes of death in
young children globally.59 If, as was the case in England, most diarrhoeal diseases in
young children are more commonly caused by poor hygiene and fly-borne contamination
of food than by contaminated water, then much more investment in fecal disposal will be
required to reduce diarrhoeal mortality further. In affluent countries it proved much
harder to remove excrement from cities and to treat sewage than to provide uncontamin-
ated water.
Mortality began to improve in older adults after c.1900 in England (with the excep-
tion of the oldest ages, 85 years and over, where substantial improvements occurred only
in the second half of the twentieth century) (Figure 1.4b). However, here the patterns
were more complex. Figure 1.5 shows death rates by cause for 60–64-year-old men and
women in England between 1891 and 1967. Whereas improvements at younger ages
reflected mainly falls in infectious disease mortality, the main gains in life expectancy at
ages 40 and over from 1900 were a consequence of reductions in deaths attributed to
tuberculosis, other respiratory infections (especially pneumonia and influenza), cardiovas-
cular diseases (strokes and heart disease), and ‘other’ causes (Figure 1.5). The latter cat-
egory included mainly diseases related to the stomach, liver, and kidneys and was
supposed by Samuel Preston to contain a substantial cardiovascular component,60 but
also included diseases of infectious origins (such as acute nephritis caused by streptococcal
infection).
Some of the patterns in Figure 1.5 reflect changes in diagnostic accuracy (and espe-
cially the transfer of deaths from ill-defined categories into specific categories, including
cancers). However, similar age-specific and cause-specific patterns of mortality decline
have been observed in a variety of populations at different stages of economic
development.61 Preston demonstrated, using long-run cause of death data for 42 coun-
tries, that falls in cardiovascular disease made a major contribution to the early stages of
mortality decline, and he attributed this both to the tendency of respiratory infections in
particular to trigger heart attacks, and to longer term effects of infections on susceptibility
to chronic non-communicable conditions.
Infectious diseases may influence non-communicable diseases in a variety of ways,
and on a variety of time scales. However, the magnitude of effects of early-life infec-
tions on health in adulthood remains hotly debated.62 There are clear examples of
specific pathways from childhood infection to adult disease, as in the case of rheum-
atic fever and valvular heart disease or Helicobacter pylori infection and stomach
cancer.63 However, at the population level, the influences of early-life disease environ-
ments are less obvious. Life expectancy at older ages bears little relationship to levels
of infection amongst the same cohorts during childhood (as gauged by childhood
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mortality rates in these cohorts). Elderly cohorts in countries such as Japan and Italy
with relatively high levels of historic childhood mortality now enjoy some of the high-
est life expectancies in the world.64 The synergies between different causes of death
remain an under-researched area.
The age of degenerative diseases (1940–present)
We have divided the discussion of English mortality patterns at 1940 because the devel-
opment of antibiotics in the late 1930s and early 1940s marked a turning point in the
capacity to cure disease. Most health innovations up to this point were preventative –
they reduced exposure to disease. Antibiotics, on the other hand, could be used to cure
infections.65
The discovery of the bactericidal properties of protonsil in 1931 led to the proliferation of
related ‘sulfa drugs’ that came into wide use in Europe and the USA by the late 1930s. Sulfa
drugs were effective against a narrow but important range of bacterial infections, including
the streptococcal strains responsible for puerperal fever in recently delivered women and
streptococcal wound infections, but not the streptococcal strains that cause scarlet fever.
Their impact on maternal mortality was dramatic.66 Neonatal mortality, particularly deaths
in the first week of life, also declined precipitously with the introduction of sulfa drugs. Anne
Løkke has argued persuasively that antibiotics were key in making caesarean deliveries safe
and that this meant that difficult deliveries ended more frequently in a successful live birth,
rather than stillbirth and maternal infection.67 Sulfa drugs also proved effective in treating
pneumonia but had no impact on tuberculosis.
Penicillin was developed in the 1930s and widely used from 1944. It proved effective
against wound infections and was widely deployed in the closing stages of WWII by the
American and British armies. Of even greater significance was the discovery in 1946 that
streptomycin cured tuberculosis. Nonetheless, the immediate impact of penicillin-type
drugs on life expectancy trends was slight (Figure 1.2b). Even in the case of tuberculosis,
the impact in Britain was much smaller than it would have been had penicillin been dis-
covered several decades earlier. Tuberculosis mortality declined enormously in the late
nineteenth century and the first half of the twentieth century, before penicillin (Figure
1.6). Nonetheless, the advent of penicillin marked a decisive break, and, within ten years
of its use, most sanatoria for the treatment of tuberculosis sufferers had been converted
to ski resorts, psychiatric hospitals, and for other uses.
Importantly, the apparently small contribution of the discovery of antibiotics to life
expectancy trends masks their enormous contribution over the last 70 years to the treat-
ment of non-communicable diseases. Before 1950, surgery remained a very dangerous
procedure, despite very significant developments in sterile procedures and wound treat-
ment. Many of the gains in survival from heart disease and cancers in the last 50 years
depended and continue to depend on surgical interventions that would have involved
substantial risk before the advent of penicillin.68 Chemotherapy, which reduces the
patient’s resistance to infection, also relies on the prophylactic use of antibiotics to reduce
the risk of opportunistic infections, as does organ transplant technology.
In European populations, infectious diseases had been controlled to a great extent by
1940 using methods that prevented transmission or raised population resistance (rather
than cured infection per se). These older methods of disease prevention were further
enhanced in the second half of the twentieth century by the development or wider
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implementation of new vaccines against a range of infectious diseases, including measles,
pertussis, yellow fever, tuberculosis, hepatitis, typhus, typhoid, polio, pneumonia, and
chickenpox.
An example of this mix of preventive and curative approaches is tuberculosis. Tuber-
culosis was (and remains) a major cause of mortality globally. The BCG vaccine against
tuberculosis was developed in the 1920s but was only widely used after WWII. Antibiot-
ics, BCG, and surveillance were then used in a three-pronged strategy to identify and
treat those infected, to reduce transmission, and to immunize the population against
infection. In addition, some of the declines in tuberculosis over the latter half of the
twentieth century reflect the same factors in operation in affluent countries before the
advent of antibiotics and BCG vaccine, including better nutrition. However, tuberculosis
resurged in the 1990s as an opportunistic infection in HIV-affected individuals and
because of the development of strains resistant to multiple types of antibiotic treatment.
BCG immunization does not face the same problem of evolved resistance, and it remains
routine in most low- and middle-income countries.69 However, its efficacy varies. BCG is
protective against tuberculosis infection in infants, but the efficacy of BCG against adult
respiratory forms of the disease varies with latitude and age at immunization, with effi-
cacy ranging from zero at low latitudes to 60–80 per cent protection at latitudes above
40 degrees.70 Therefore, the relative contributions of antibiotics, immunization, and
improvements in living conditions to global declines in tuberculosis are very geographic-
ally as well as chronologically heterogeneous.
The globalization of mortality decline, 1950 onwards
Famines and major epidemic outbreaks began, slowly, to recede in much of the world in
the late nineteenth century and the first half of the twentieth century so that, by the time
the world emerged into the spotlight of global statistics in the 1950s, profound changes
had already taken place in much of the world’s population. In India, for instance, large
upswings in mortality caused by famine, bubonic plague, and smallpox diminished sub-
stantially after 1920. Tim Dyson and Monica Das Gupta attributed this stabilization of
mortality to colonial policies that improved food distribution, monitored plague out-
breaks, and increased smallpox vaccination coverage.71 A similar stabilization of mortal-
ity after 1920 is evident in Jamaica, where a precocious public health administration,
education, and registration system facilitated rapid gains in life expectancy from this
date, with the fastest gains in the period 1925–1940.72 In many African societies, the
progressive eradication of smallpox, culminating in the WHO global campaign from
1950 to 1980, must have had an effect on populations with hitherto low rates of vaccin-
ation as profound as that in early nineteenth-century Europe.
While the early gains in life expectancy in affluent countries had increased global
inequalities in health by the mid-twentieth century, the period after 1950 witnessed very
substantial convergence, at the national level (Figure 1.3). In poor countries, the process
of infectious disease control, so drawn out in England, was enormously accelerated in
the second half of the twentieth century by the rapid availability of medical and public
health technologies and knowledge. These included immunization, antibiotics, germ
theory and sanitation technologies, and insecticides. The rapidity of global improvements
in mortality is all the more astonishing when one considers the challenging disease envir-
onments in which some of these changes occurred. England’s slow mortality decline took
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place in a temperate island setting, with a low burden of arthropod-borne infections and
relatively easy means of controlling disease importation through quarantine. Populations
in low-altitude tropical areas faced much higher disease burdens as a consequence of cli-
matic and ecological conditions, especially in Africa where co-evolution between patho-
gens and humans and other primates was very longstanding. Moreover, these rapid
mortality declines have occurred in the context of ever-increasing globalization and
urbanization.
Some of the very rapid gains made in the decade after WWII must be attributed to
the widespread use of DDT to destroy the insect vectors of malaria, trypanosomiasis,
yellow fever, and typhus.73 Malaria in particular was a major cause of mortality and
morbidity across tropical Africa, Central and South America, and South and South-East
Asia (including southern China). Malarial infection induces only short-lived immunity,
but, where malarial exposure is most intense, the burden of infection falls mainly on very
young children and immigrants (because these groups lack immunity). Malarial mortality
was dramatically reduced by DDT spraying of mosquito breeding sites and, more lat-
terly, by anti-malarial drugs and the use of bed nets. However, the complexity of the
malarial life cycle, the evolution of drug resistance, and regulation of insecticide use has
repeatedly threatened these gains.
The huge gains in global life expectancy since 1950 were accompanied by very substantial
economic development. The extent of these changes over the last 70 years remains very
under-appreciated. Today over 90 per cent of the world’s population lives in ‘middle-
income’ or ‘high-income’ countries, and half lives in states with below-replacement levels of
fertility (that is, with total fertility rates below 2.1 children per woman).74 Economic growth
has coincided with rapid increases in education, medical technologies, and falls in fertility, as
well as enormous social and cultural changes. Given the rapidity of change, is it possible to
identify the key distal drivers of mortality improvements?
The difficulties involved in teasing out the relationships between economic growth
and demographic outcomes can be illustrated using so-called ‘Preston curves’. In
a landmark paper in 1975, Samuel Preston produced a series of plots of national life
expectancy by national income per capita (adjusted for change in nominal value of GDP
over time), for 1900, 1930, and 1960.75 Figure 1.7 plots similar relationships for 1960
and 2018, and for the United States in 1900. As Figure 1.7 demonstrates, there is
a strong relationship in any given year between the per capita income of a country and
its average life expectancy at low levels of income. Conversely, above a certain threshold,
income ceases to be associated with further gains in life expectancy. Crucially, however,
although this relationship between income and life expectancy appears strong in any
given year, the life expectancy that could be achieved for a given income has risen con-
sistently over time. In 1900 the United States was the richest country in the world; how-
ever, it was unable to procure an average life expectancy for its citizens of more than 50
years. By 1960 countries with the same average income as the United States in 1900 had
an average life expectancy of more than 60 years. By 2018 for the same income the
average life expectancy was over 70 years.
Preston’s interpretation of these patterns was that rising national incomes could only
account for a small fraction (less than a quarter) of improvements in life expectancy over
time.76 He argued that health had in fact grown cheaper over time so that technologies that




Figure 1.7 ‘Preston curves’; national life expectancies in relation to income per capita.
GDP per capita measures are expressed in international dollars (fixed 2011 prices). ‘Oil-rich’ states are defined
as those which derive 10 per cent or more of GDP from oil rents. HIV-affected states are those with an esti-
mated HIV prevalence of 5 per cent or more of adults aged 15–49.
Sources: HIV prevalence: CIA, www.cia.gov/library/publications/the-world-factbook/rankorder/raw
data_2155.txt; GDP per capita and oil rents: World Bank, compiled by www.gapminder.org (downloaded Feb-
ruary 10, 2020); M. Roser, E. Ortiz-Ospina, and H. Ritchie, ‘Life Expectancy’, published online at OurWorl-
dInData.org (2020), retrieved from https://ourworldindata.org/life-expectancy.
P A T T ERN S O F D EATH , 1 8 0 0 – 2 0 2 0
39
Other scholars have argued that state interventions or cultural factors were more import-
ant than economic growth to improving longevity. Jack Caldwell drew on examples of
‘high-performing’ poor countries or states that managed to achieve very high levels of life
expectancy before they achieved rapid rates of economic growth. These included Sri Lanka,
Costa Rica, Jamaica, Kerala (in India), China, Cuba, and Vietnam.77 Analyzing the non-
communist states, Caldwell concluded that these ‘high-performers’ were characterized by
cultural traits including relatively high female status (and therefore relatively high levels of
female education), institutional factors that included fairly egalitarian access to healthcare
(such as immunization, rural clinics, and ‘barefoot doctor’ services), and either relatively
egalitarian access to food or a social safety net that operated in times of dearth.78 He also
drew attention to the poor performance of oil-rich states, which had relatively high incomes
but unimpressive life expectancies (as is evident in Figure 1.7a).
More recently James Riley analyzed a wider set of early-achieving ‘high performers’
and concluded that there were in fact many pathways to rapid health improvements.79
Riley’s high performing states (relative to GDP) included a number of oil-rich popula-
tions (in particular, Oman and Venezuala), although it is only in recent decades that the
generally poor performance of oil-rich countries has diminished (Figure 1.7b). Riley’s
work emphasizes the heterogeneity of possible routes to low mortality.
Improvements in mortality since 1800 were associated with very profound economic,
technological, and social changes and defy monocausal explanations. Explanations fall
largely into two camps, those invoking economic development and rising living standards,
especially improved nutrition,80 and those which attribute the bulk of improvement to
public health measures.81 Predictably, the evidence is ambiguous. The ubiquity of mor-
tality improvements in global populations at very different levels of income, development,
and life expectancy points to the potential multiplicity of pathways and perhaps to the
importance of fertility decline and education.82 Additionally, there may be bi-directional
influences between health and income. Robert Fogel described a ‘techno-physio revolu-
tion’, where improvements in diet increased human productivity, which then further
improved output and economic development in a virtuous circle of improving health and
wealth.83 Easterlin, on the other hand, considered that both economic growth and mor-
tality improvements derived from the growth of scientific knowledge but were not them-
selves strongly causally related.84 The relative importance of household income, medical
technologies, public health interventions, and wider changes in fertility and education
remains controversial, and this may be because their influence varied widely. This is
almost inevitably the case, because local cultures, histories, and ecological conditions
varied so widely.
The future
What can the past tell us about potential future trends? Perhaps the most important pat-
tern to note is that life expectancy has generally continued to rise, despite the enormous
challenges posed by rapid population growth and urbanization. These factors would have
caused unsustainable increases in mortality in traditional societies, and yet now famines
are rare, and most urban populations have higher life expectancies than their rural coun-
terparts. Remarkably, the trend in ‘best case’ life expectancy (for the national population
with the highest life expectancy in any given year) has continued to rise fairly linearly (at
a rate of approximately three years of extra life per decade) since 1840.85 This suggests
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that any biological limits to human life expectancy, if they exist, are yet to be encoun-
tered. Therefore, future trends will probably continue to depend on human capacity to
overcome old threats and new challenges to human health.
These threats are very substantial, potentially even larger than the factors that drove the
numerous setbacks to longevity gains over the last two centuries. Reasons why survival gains
could falter or even reverse include the emergence of novel pathogens (through inter-species
transfers and autonomous changes in pathogen properties), the multifarious effects of climate
change (on environmental conditions, migration, and disease vector ranges), antibiotic resist-
ance, and obesity. On the positive side, a concerted move towards clean energy will make cities
substantially healthier, and this is where the majority of the world’s population now lives.
Urban populations now generally enjoy higher life expectancies than rural populations,
a striking reversal of historic norms. However, this advantage reflects, in part, the higher
wealth of cities and superior access to public health measures (sewerage, clean water, immun-
ization programs) and to clinics and hospitals, which outweigh the disamenities of crowding
and poor air quality. This balance will change as air pollution reduces but also as rural popu-
lations gain greater access to health facilities. The balance of these and other trends will help
to determine whether individual and global inequalities in health and longevity widen or
narrow in the twenty-first century.
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